These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18341375)

  • 1. The EUGOGO consensus statement on the management of Graves' orbitopathy: equally applicable to North American clinicians and patients.
    Bahn R
    Thyroid; 2008 Mar; 18(3):281-2. PubMed ID: 18341375
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
    Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM
    Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
    Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
    Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.
    Bartalena L; Macchia PE; Marcocci C; Salvi M; Vermiglio F
    J Endocrinol Invest; 2015 Apr; 38(4):481-7. PubMed ID: 25722226
    [No Abstract]   [Full Text] [Related]  

  • 7. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
    Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
    Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy.
    Sundar G; Chiam N; Lun K; Koh V
    Orbit; 2014 Oct; 33(5):319-25. PubMed ID: 25121573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
    Wiersinga WM
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
    Orgiazzi J
    Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
    [No Abstract]   [Full Text] [Related]  

  • 12. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
    Perros P; Žarković M; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi A; Bournaud C; Brix TH; Covelli D; Ćirić S; Daumerie C; Eckstein A; Fichter N; Führer D; Hegedüs L; Kahaly GJ; Konuk O; Lareida J; Lazarus J; Leo M; Mathiopoulou L; Menconi F; Morris D; Okosieme O; Orgiazzi J; Pitz S; Salvi M; Vardanian-Vartin C; Wiersinga W; Bernard M; Clarke L; Currò N; Dayan C; Dickinson J; Knežević M; Lane C; Marcocci C; Marinò M; Möller L; Nardi M; Neoh C; Pearce S; von Arx G; Törüner FB
    Br J Ophthalmol; 2015 Nov; 99(11):1531-5. PubMed ID: 25953846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' orbitopathy: Diagnosis and treatment.
    Drui D; Du Pasquier Fediaevski L; Vignal Clermont C; Daumerie C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):656-664. PubMed ID: 30177259
    [No Abstract]   [Full Text] [Related]  

  • 14. THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.
    Campi I; Vannucchi G; Salvi M
    Eur J Endocrinol; 2016 Sep; 175(3):R117-33. PubMed ID: 27032693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A questionnaire survey on the management of Graves' orbitopathy in Europe.
    ; Perros P; Baldeschi L; Boboridis K; Dickinson AJ; Hullo A; Kahaly GJ; Kendall-Taylor P; Krassas GE; Lane CM; Lazarus JH; Marcocci C; Marino M; Mourits MP; Nardi M; Orgiazzi J; Pinchera A; Pitz S; Prummel MF; Wiersinga WM
    Eur J Endocrinol; 2006 Aug; 155(2):207-11. PubMed ID: 16868132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 18. [The expected and unexpected: key points in the 2021 European Group on Graves' Orbitopathy clinical practice guidelines for the management of Graves' orbitopathy].
    Pan Q; Lyu ZH; Guan HX
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):8-11. PubMed ID: 34979768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old and new: evidence-based evaluation of interventions for Graves' Orbitopathy.
    Ezra DG; Rose GE
    Br J Ophthalmol; 2014 Mar; 98(3):287-8. PubMed ID: 24311524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.